Alternatives to En Carta Diagnostics

Revolutionizing genomic analysis with innovative sequencing technology.

Developing breath-based diagnostics for lung diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

Developing novel immunotherapies and diagnostics for cancer.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Pioneering vision restoration therapies for severe retinal degenerations.

Developing ultrasound-mediated nonviral genetic medicines.

Developing novel male contraceptives.

Developing a new histotripsy therapeutic platform for cancer treatment.

Develops and distributes bioreactor technology for stem cell cultivation.

Elevating uterine health through innovative biomaterial therapies.

Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.

Develops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.

Advancing biopsy specimen stewardship and expanding access to precision oncology.

Cultivating wood directly into its final shape, 10,000x faster than forestry.

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Integrated life science company specializing in diagnostic testing solutions and life science raw materials.